Mel Billingsley, Ph.D., is president and CEO of the Life Sciences Greenhouse, professor of pharmacology at Pennsylvania State University Milton S. Hershey College of Medicine (MSHCM), and professor of biotechnology and entrepreneurship, Penn State University - Harrisburg, PA campus. His background includes rich and varied experience as a researcher, educator and investor, as well as a long history of actively fostering the advancement of technology within the larger community. He has an undergraduate degree in biophysics and microbiology from the University of Pittsburgh, a doctoral degree in pharmacology from George Washington University, and a postdoctoral degree in neuropharmacology from Yale School of Medicine.
